“Several Risk Factors and a Few Curve Balls” Dr. Rustem Dautov describes a complex CHIP case in which Impella CP® played a vital role. As interviewer Dr. Shon Chakrabarti notes, it was a case with “several risk factors and a few curve balls.” Rustem Dautov, MD, FRACP, PhD, is an interventional cardiologist at The Prince … Continue reading “LVEF Improvement After Complex CHIP Case with Impella Support”
Dr. Aaron Grantham of St. Luke’s Mid-American Heart Institute presents how to measure the added value of high-risk PCI by first understanding the underlying economics. Given the cost cutting nature of hospital administrators, health care providers must know the data that determine costs and develop a programmatic approach to measuring value. Tweet this, subscribe or join … Continue reading “Managing the Economics of CHIP and Making the Case for Added Value”
Dr. Marty Leon outlines the important role of hemodynamic support for complete revascularization in CHIP patients. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI ICP-075-16
University of Washington’s Dr. Mark Reisman describes how to develop a CHIP Protected PCI program. In this comprehensive presentation, Dr. Reisman details out the proper steps which include building a multidisciplinary heart team and fostering a CHIP alliance with other hospitals. Tweet this, subscribe or find an Impella training course near you.
Dr. Robert Riley of University of Washington Medical Center describes how Fellows can gain experience in treating CHIP patients through a wide variety of resources. Tweet this, subscribe or join the conversation by following us on Twitter: @ProtectedPCI NPS-153-16.v2
Dr. Raja Hatem of Columbia University Medical Center discusses the importance of recognizing vital signs early in a cardiogenic shock case with multi-vessel intervention.
Dr. Raja Hatem discusses the CHIP Fellowship Program designed to train cardiologists to help the underserved, high-risk patients who exhibit low EF, coronary artery calcification, multivessel disease or chronic total occlusion. IMP-231
Dr. James McCabe of the University of Washington uses case examples to discuss public reporting and outcomes data and how it affects high-risk PCI programs and procedures. Dr. McCabe presented this at the Expanding Your Practice to Include Complete Revascularization in Higher-Risk Indicated Patients sponsored by the Cardiovascular Research Foundation course held in Seattle this … Continue reading “The Current & Future State of High Risk PCI in a World of Increasing Public Scrutiny”
Dr. Amir Kaki of DMC Heart Hospital shares an Impella case that illustrates the benefits of early hemodynamic support in patients with extensive myocardium risk. Tweet this, subscribe or find educational opportunities near you.